arrow
G

Giulia Marchetti

university of milan
H指数:41
被引数:7,796

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

"The past is never dead; it's not even past"⁎. From EuCARE experience to future pandemics: evidence-based lessons for a prepared Europe

《过去从未死去;它甚至还没有过去》⁎。从EuCARE经验到未来大流行病:为准备充分的欧洲提供的循证教训

2026-10-230
OAAI
In-hospital antibiotic consumption in Lombardy, Italy (2017–2024): a retrospective analysis of regional administrative data

意大利伦巴第大区2017–2024年院内抗生素消耗量:一项区域行政数据的回顾性分析

2026-09-070
OAAI
Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study

在意大利,HIV感染者抗逆转录病毒治疗启动时的肥胖与心血管疾病、癌症或死亡的长期风险:一项前瞻性队列研究

2026-08-010
PRE
Increased in-hospital mortality in immunocompromised individuals hospitalized with COVID-19 during the global pandemic, a multinational cohort study in the EuCARE project

全球大流行期间免疫抑制个体因COVID-19住院期间院内死亡率的增加:EuCARE项目中的多国队列研究

2026-05-080
OA
Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort

Bictegravir/emtricitabine/tenofovir alafenamide在HIV感染者临床实践中的应用:BICSTaR观察性队列中关键人群的最终24个月有效性与安全性结局

2025-12-3110
PRE
Implementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME project

基于全国性调查,为INSIEME项目在意大利医院实施感染预防和控制组件

2025-10-220
OA
Incidence, risk factors and outcomes of healthcare-associated bacterial infections in COVID-19 patients receiving respiratory support: a retrospective cohort study

新型冠状病毒肺炎患者接受呼吸支持治疗中,医院获得性细菌感染的发病率、危险因素及结局:一项回顾性队列研究

2025-09-050
OAAI
HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study

HIV口腔前暴露预防效果、依从性及停药情况在意大利多中心获取计划中的研究:ItaPrEP研究

2025-09-013
OAAI
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry

评估高治疗经验且多重耐药个体在抑制性抗逆转录病毒治疗下HIV-1 DNA耐药性演化的纵向研究:PRESTIGIO登记研究

2025-09-010
OAAI
All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry

四类耐药人类免疫缺陷病毒患者全因死亡率:一项基于PRESTIGIO登记数据的匹配队列分析

2025-08-010
OAAI
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation

达芦那韦组与利托那韦增强型达芦那韦组在晚期HIV患者中的三联一线方案有效性比较:一项试验模拟研究

2025-06-010
OAAI
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort

长效卡博特格拉韦/利匹韦林治疗中断的有效性及预测因素:来自Icona队列的真实世界数据,用于研究病毒学受抑制的HIV感染者

2025-06-011
PRE
Cefiderocol for Gram-negative infections: comparing monotherapy and combination therapy in the multicenter CEFI-BAC study

西地尼布用于革兰氏阴性菌感染:比较多中心CEFI-BAC研究中单药疗法与联合疗法

2025-04-240
OA
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of post-COVID-19 condition in vulnerable populations

ORCHESTRA Delphi共识:易感人群新冠后状态的诊断与治疗管理

2025-04-170
PRE